Navigation Links
Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
Date:6/9/2009

SAN DIEGO, June 9 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed new distribution agreements for its VerifyNow(R) System in both Israel and Cyprus. Medtechnica, Ltd. will oversee distribution of all VerifyNow products in Israel, while Z.S. Curemed, Ltd. will be the sole distribution channel in Cyprus. These distribution agreements continue to expand Accumetrics' reach in both scope and geography, and add to the growing numbers of countries outside of the United States and Europe where physicians have access to the VerifyNow System.

The VerifyNow System assesses response to antiplatelet therapies, such as aspirin, Plavix(R) and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.

"We're extremely excited to see distribution of our VerifyNow System reach Israel and Cyprus. We have chosen these partners based on their demonstrated expertise and knowledge of our markets in their respective territories," said Timothy I. Still, President and CEO of Accumetrics. "These partnerships continue to emphasize our focus on expanding our global distribution channels, and support our vision of providing physicians worldwide access to critical information for managing their cardiovascular patients on antiplatelet therapies."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product for prasugrel and FDA-cleared products for aspirin, Plavix, ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc., ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis.

About Medtechnica, Ltd.

Founded in 1958, Medtechnica, Ltd. has become one of the largest medical equipment suppliers in Israel. Medtechnica is the sole distributor, in Israel, of leading international manufacturers of medical equipment, including Phillips Medical Systems, Olympus Medical, Maquet, 3M Medical and among others.

About Z.S. Curemed, Ltd.

Established in 2001 in Cyprus, Curemed has grown to become one of the leading companies in the sectors of Interventional Cardiology and Intensive Care. Curemed focuses on promotion, sales and support of innovative Interventional Cardiology and Intensive Care devices to Public and Private Hospitals in Cyprus. Curemed conforms to EN ISO 9001: 2008.

    CONTACT:
    Jules Abraham
    Lippert/Heilshorn & Associates
    212-838-3777
    jabraham@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
2. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
3. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
4. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
5. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
6. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
7. Morphotek(R), Inc. Announces FDA Acceptance of Investigational New Drug Application for MORAb-004, a Monoclonal Antibody for the Treatment of Solid Tumors
8. Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
9. Life Spine Announces Appointment of Todd Fanning as Vice President of Sales
10. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
11. ThinIdentity(TM) Announces Two New Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... Stephanie Hebert Insurance Agency, serving families of ... charity campaign. As part of their ongoing community involvement program, funds are now ... children deserve a voice, and in the spirit of neighbors helping neighbors in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... A man who has struggled to quit smoking, ... Laser Therapy , was determined to find solutions to his problems – and he did. ... Digest is ready to introduce his breakthrough inventions to the world and better people's ...
(Date:2/8/2016)... York, NY (PRWEB) , ... February 08, 2016 , ... ... are too much to handle, you are not alone. According to the Center for ... include heart disease, stroke, type 2 diabetes and certain types of cancer, some of ...
(Date:2/8/2016)... Hilton Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... Head and surrounding areas with a vital new community enrichment program, has teamed up ... to local women and children suffering from intimate abuse. To support all those victimized ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local ... the greater Venice, FL area, has initiated a fundraiser for a two year ... just four days after Christmas. To support this beautiful child who is facing ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, ... report, "Cardiovascular Surgery Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. ... comprehensive information on the pipeline products with comparative ... development. The report reviews major players involved in ...
(Date:2/8/2016)... 2016  Labvantage Lx, a newcomer to the ... sexual enhancement product, EnduramenT. Setting a new standard ... a patented biomedical breakthrough molecule that promotes the ... responsible for many biological functions including erectile function. ... Forgoing the use of prescription medications, scientists working ...
(Date:2/8/2016)... TOKYO and FAIRFIELD, N.J. ... (Otsuka) and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that ... exclusive development and commercialization rights for OPA-15406 in the ... agreement also provides manufacturing rights.  OPA-15406 is a topical, ... for atopic dermatitis. --> ...
Breaking Medicine Technology: